Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto

Details for Australian Patent Application No. 2002220195 (hide)

Owner Signal Pharmaceuticals, Inc.

Inventors Erdman, Paul E.; Bhagwat, Shripad S.; Parnes, Jason S.; Satoh, Yoshitaka; Palanki, Moorthy S. S.; Kois, Adam; Macfarlane, Karen J.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2002220195

PCT Pub. Number WO02/46171

Priority 60/251,816 06.12.00 US

Filing date 5 December 2001

Wipo publication date 18 June 2002

Acceptance publication date 24 August 2006

International Classifications

C07D 239/42 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

24 August 2006 Application Accepted

  Published as AU-B-2002220195

24 May 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002220196

2002220194-Process for sulfiding catalyst in a column